599 related articles for article (PubMed ID: 18061531)
1. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and oral oncogenesis.
Vairaktaris E; Spyridonidou S; Goutzanis L; Vylliotis A; Lazaris A; Donta I; Perrea D; Yapijakis C; Patsouris E
Anticancer Res; 2007; 27(6B):4185-93. PubMed ID: 18225590
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.
Derka S; Vairaktaris E; Papakosta V; Vassiliou S; Acil Y; Vylliotis A; Spyridonidou S; Lazaris AC; Mourouzis C; Kokkori A; Moulavasili P; Perrea D; Donta I; Yapijakis C; Patsouris E
Oral Oncol; 2006 May; 42(5):540-50. PubMed ID: 16464633
[TBL] [Abstract][Full Text] [Related]
4. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
[TBL] [Abstract][Full Text] [Related]
5. EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.
Vairaktaris E; Loukeri S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Papakosta V; Lazaris A; Agrogiannis G; Yapijakis C; Perrea D; Patsouris E
In Vivo; 2007; 21(5):791-6. PubMed ID: 18019413
[TBL] [Abstract][Full Text] [Related]
6. H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.
Vairaktaris E; Papakosta V; Derka S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Lazaris A; Kokkori A; Moulavassili P; Loukeri S; Perrea D; Donta I; Yapijakis C; Patsouris E
In Vivo; 2008; 22(5):621-8. PubMed ID: 18853758
[TBL] [Abstract][Full Text] [Related]
7. Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.
Vairaktaris E; Moulavassili P; Loukeri S; Spyridonidou S; Yapijakis C; Vassiliou S; Nkenke E; Vylliotis A; Papakosta V; Lazaris A; Patsouris E
J Musculoskelet Neuronal Interact; 2007; 7(2):185-90. PubMed ID: 17627089
[TBL] [Abstract][Full Text] [Related]
8. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
9. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
[TBL] [Abstract][Full Text] [Related]
10. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
[TBL] [Abstract][Full Text] [Related]
11. Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential.
Vairaktaris E; Goutzanis L; Kalokerinos G; Yannopoulos A; Yapijakis C; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris AC; Tesseromatis C; Patsouris E
In Vivo; 2007; 21(4):615-21. PubMed ID: 17708355
[TBL] [Abstract][Full Text] [Related]
12. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
13. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.
Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Patsouris E
In Vivo; 2007; 21(5):745-50. PubMed ID: 18019407
[TBL] [Abstract][Full Text] [Related]
15. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
16. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
[TBL] [Abstract][Full Text] [Related]
17. An animal model for oral cancer.
Slaga TJ; Gimenez-Conti IB
J Natl Cancer Inst Monogr; 1992; (13):55-60. PubMed ID: 1382504
[TBL] [Abstract][Full Text] [Related]
18. FGFR-2 and -3 play an important role in initial stages of oral oncogenesis.
Vairaktaris E; Ragos V; Yapijakis C; Derka S; Vassiliou S; Nkenke E; Yannopoulos A; Spyridonidou S; Vylliotis A; Papakosta V; Loukeri S; Lazaris A; Tesseromatis C; Tsigris C; Patsouris E
Anticancer Res; 2006; 26(6B):4217-21. PubMed ID: 17201136
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
